Serina Therapeutics, Inc. Class of Warrant or Right, Outstanding
Serina Therapeutics, Inc. (SER) had Class of Warrant or Right, Outstanding of 2.97 million shares as of 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-03-25
- 2025-12-31: Class of Warrant or Right, Outstanding 2.97M shares.
- 2025-06-30: Class of Warrant or Right, Outstanding 1.50M shares.
- 2025-03-31: Class of Warrant or Right, Outstanding 1.50M shares.
- 2024-12-31: Class of Warrant or Right, Outstanding 2.00M shares.
| Period end | Class of Warrant or Right, Outstanding | Class of Warrant or Right, Outstanding as first filed |
|---|---|---|
| 2025-12-31 | 2.97M shares 10-K · filed 2026-03-25 | |
| 2025-06-30 | 1.50M shares 10-Q · filed 2025-08-11 | |
| 2025-03-31 | 1.50M shares 10-Q · filed 2025-05-08 | |
| 2024-12-31 | 2.00M shares 10-K · filed 2026-03-25 | |
| 2024-06-30 | 473.68K shares 10-Q · filed 2024-08-09 | |
| 2023-12-31 | 359.00K shares 10-K · filed 2025-03-24 | 473.68K shares 10-Q · filed 2024-08-09 |
| 2023-06-30 | 358.51K shares 10-Q · filed 2024-08-09 | |
| 2023-03-31 | 756.43K shares 10-Q · filed 2023-05-12 | |
| 2022-12-31 | 358.51K shares 10-Q · filed 2024-08-09 | 454.55K shares 10-K · filed 2023-03-31 |
| 2022-09-30 | 1.64M shares 10-Q · filed 2022-11-10 | |
| 2022-06-30 | 2.50M shares 10-Q · filed 2022-08-12 | |
| 2022-03-31 | 2.66M shares 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |